Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution. [electronic resource]
Producer: 20020212Description: 44-51 p. digitalISSN:- 0026-0495
- Aged
- Blood Glucose -- analysis
- Chromans -- administration & dosage
- Diabetes Mellitus, Type 2 -- blood
- Dose-Response Relationship, Drug
- Fatty Acids, Nonesterified -- blood
- Female
- Fibrinogen -- metabolism
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- metabolism
- Insulin Resistance -- physiology
- Insulin Secretion
- Lipoproteins -- blood
- Lipoproteins, HDL -- blood
- Lipoproteins, VLDL -- blood
- Male
- Middle Aged
- Plasminogen Activator Inhibitor 1 -- blood
- Thiazoles -- administration & dosage
- Thiazolidinediones
- Troglitazone
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.